NUTRIPHARM
InactiveOverview
- Staff
- 5.9 FTE
- Equity
- €238,623
- Loss
- -€49,538
- Parent
- TA Finances · 100%
SignalsneutralPrior bankruptcyNo filing for yearsFiled after the deadlineShow the evidence
Signals
This company filed its last 7 accounts on average 19 days after the deadline; the Belgian median for financial year 2018 is 2 days before the deadline, and 42% of all filings were late.
Searched, nothing found (1)
- Bankruptcy closure (by liquidation)Enterprise Court of Liège, Liège…
- OpeningEnterprise Court of Liège, Liège…
- Annual accounts filedfinancial year 2018 · full…
Financials · financial year 2018, full format
2018 annual accounts filed late (30 days) Filed on 30 August 2019, deadline 31 July 2019 (7 months after the close on 31 December 2018, Companies Code art. 3:10). Source: NBB, 2019-61800534.
| Line | 2018 |
|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €64,020 |
| Gross operating margin9900 | €371,058 |
| Operating profit (loss)9901 | -€32,071 |
| Recurring financial income75 | €2,801 |
| Recurring financial charges65 | €19,100 |
| Profit (loss) for the period before taxes9903 | -€48,370 |
| Income taxes67/77 | €1,168 |
| Profit (loss) for the period9904 | -€49,538 |
| Profit (loss) for the period to be appropriated9905 | -€49,538 |
| Line | 2018 | |
|---|---|---|
| Assets | ||
| Total assets20/58 | €613,677 | |
| Fixed assets21/28 | €202,409 | |
| Intangible fixed assets21 | €77,034 | |
| Tangible fixed assets22/27 | €97,851 | |
| Financial fixed assets28 | €27,523 | |
| Current assets29/58 | €411,268 | |
| Stocks and contracts in progress3 | €145,810 | |
| Amounts receivable within one year40/41 | €231,140 | |
| Cash at bank and in hand54/58 | €33,906 | |
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €613,677 | |
| Equity10/15 | €238,623 | |
| Contributions10/11 | €191,068 | |
| Reserves13 | €1,958 | |
| Profit (loss) carried forward14 | €45,596 | |
| Amounts payable17/49 | €375,054 | |
| Amounts payable within one year42/48 | €371,009 | |
| Trade debts44 | €148,890 | |
| Line | 2018 |
|---|---|
| Profit (loss) for the period9904 | -€49,538 |
| + Depreciation and write-downs630 | €64,020 |
| Operating cash flow (approximation) | €14,483 |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Insolvency mandates
1 mandate| Role | Name | Tenure |
|---|---|---|
| Trustee | Pierre Henry Boulevard De La Sauveniere 117, 4000 Liege 1- . 6636 Belgisch Staatsblad — 04.02.2020 — Moniteur Belge |
29-01-2020 → 18-10-2022 |
Owners and capital
Owners
1 ownerChain of control
- TA Finances
- NUTRIPHARM
Highest known parent: TA Finances. The sources do not say who stands above it.
Owners 1
- TA Financesparent100%
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Group and network
Connections & network
No directors read yet: 0 of 14 Gazette acts processed.
History
Acts, filings and financial milestones
About the unread acts
We know of 14 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.